Brief: Annexin Q2 Net Loss Narrows To SEK 9.0 Mln
Aug 19 (Reuters) - Annexin Pharmaceuticals AB (publ)
ANNX.ST :
* ANNEXIN PHARMACEUTICALS AB (PUBL) - Q2 NET LOSS SEK 9.0
MILLION
VERSUS LOSS SEK 11.6 MILLION YEAR AGO
Source text for Eikon: ID:nWkr6DqCLw
Further company coverage: ANNX.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Annexin Pharmaceuticals AB (publ)
See all newsBrief: Annexin Pharmaceuticals Q3 Net Loss At SEK 9.5 Mln
Brief: Annexin Pharmaceuticals Q2 2026 Net Loss SEK 11.6 Mln
Brief: Annexin Pharmaceuticals Gets International Nonproprietary Name Drug Candidate Anxv
Brief: Annexin Pharmaceuticals Updates On Nine Patients Treated In Nexus Study
Brief: Annexin's Rights Issue 98% Subscribed